Nrx Pharmaceuticals Stock Price, News & Analysis
Company Description
Nrx Pharmaceuticals (NASDAQ: NRXPW) is a publicly traded company in the Pharmaceutical Preparations sector.
NRXPW stock has declined 67.2% over the past year. Shares last traded at $0.0243.
On a trailing twelve-month basis, Nrx Pharmaceuticals reported revenue of $0 with net income of -$25.1M.
This page provides a comprehensive overview of NRXPW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Nrx Pharmaceuticals (NRXPW) stock last traded at $0.0243. Over the past 12 months, the stock has lost 67.2%.
Latest News
SEC Filings
Nrx Pharmaceuticals has filed 5 recent SEC filings, including 1 Form 3, 1 Form 4, 1 Form 8-K, 1 Form 10-K. The most recent filing was submitted on March 24, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all NRXPW SEC filings →
Financial Highlights
operating income reached -$18.5M, and net income was -$25.1M. The company generated -$10.6M in operating cash flow. With a current ratio of 0.15, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Nrx Pharmaceuticals (NRXPW) currently stands at 1.7 thousand shares, up 2.6% from the previous reporting period, representing 0.5% of the float. Over the past 12 months, short interest has decreased by 38%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Nrx Pharmaceuticals (NRXPW) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
NRXPW Company Profile & Sector Positioning
Nrx Pharmaceuticals (NRXPW) operates in the Pharmaceutical Preparations sector and is listed on the NASDAQ.